Apollo Hospitals Gains 2.75%: 5 Key Factors Driving the Week’s Momentum

29 June: New 52-Week High Signals Strong Momentum

On 29 June 2026, Apollo Hospitals reached a new 52-week high of Rs.8,694, marking a 1.26% gain on the day. This milestone underscored the stock’s robust momentum, supported by strong fundamentals and technical positioning above all key moving averages. The stock outperformed the hospital sector by 0.53%, despite the Sensex closing flat at 35,960.98. Institutional ownership remained high at 65.61%, reflecting confidence in the company’s market leadership and earnings growth. The company’s market capitalisation stood at Rs.1,23,504 crores, representing nearly 20% of the hospital sector’s total value.

30 June: Continued Uptrend with Another 52-Week High

Apollo Hospitals extended its gains on 30 June, hitting a fresh 52-week high of Rs.8,737, a 0.34% increase from the previous close. The stock’s five-day gain reached 3.14%, maintaining its position above all major moving averages. Despite a marginal decline in the Sensex (-0.01%), the healthcare sector showed strength with the S&P BSE Healthcare index also hitting new highs. The company’s quarterly results remained impressive, with net sales of Rs.6,605.50 crore and PBDIT of Rs.1,011 crore, both all-time highs. The valuation remained attractive with an enterprise value to capital employed ratio of 8.3 and a PEG ratio of 1.8.

1 July: Open Interest Surge Indicates Market Positioning Shift

The derivatives market activity on 1 July revealed a 12.55% increase in open interest to 26,911 contracts, signalling a shift in market positioning. This rise accompanied a futures volume of 11,039 contracts and a combined futures and options traded value of approximately ₹9,950 lakhs. Despite a 0.82% dip in the stock price to Rs.8,616.80, the underlying equity remained close to its 52-week high, suggesting investors were recalibrating their directional bets rather than exiting positions. Delivery volumes surged by 57.94% compared to the five-day average, indicating increased investor participation in the cash segment. The stock’s technical indicators remained bullish, trading above all key moving averages.

2 July: Recovery and Strong Price Gain

On 2 July, Apollo Hospitals rebounded strongly, gaining 0.94% to close at Rs.8,697.55. This recovery followed the previous day’s minor correction and was supported by continued technical strength and positive market sentiment. The Sensex also advanced by 0.71%, reflecting a broadly favourable environment. The stock’s sustained trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages reinforced the medium-term uptrend. However, volume remained modest at 2,881 shares, suggesting cautious participation ahead of the week’s close.

3 July: New 52-Week High and Another Open Interest Spike

The week closed on a strong note with Apollo Hospitals hitting a new 52-week high of Rs.8,850, a 2.30% gain on the day. This marked the second consecutive day of gains, delivering a cumulative 2.91% return over 2–3 July. The stock outperformed the hospital sector by 1.12% and the Sensex by 1.63%, reflecting robust sectoral and market-wide optimism. Open interest surged by 13.49% to 32,119 contracts, accompanied by a high trading volume of 37,815 contracts in derivatives. The combined futures and options notional value exceeded ₹31,499.5 lakhs, indicating strong market conviction. Despite a sharp decline in delivery volumes by 58.27%, the stock’s technical indicators remained bullish, trading above all major moving averages and supported by positive MACD and Bollinger Bands signals.

Weekly Price Performance: Apollo Hospitals vs Sensex

Key Takeaways from the Week

Strong Price Momentum: Apollo Hospitals outperformed the Sensex by 1.44% over the week, closing at Rs.8,897.35 after hitting multiple 52-week highs, including an intraday peak of Rs.8,918.

Robust Financials: The company’s record quarterly net sales of Rs.6,605.50 crore and PBDIT of Rs.1,011 crore underpin the rally, supported by a high ROCE of 17.13% and an operating margin of 38.67%.

Elevated Institutional Confidence: Institutional ownership remains strong at 65.61%, reflecting sustained backing from large investors amid positive earnings growth of 35.3% over the past year.

Technical Strength: The stock consistently traded above all major moving averages, with bullish MACD and Bollinger Bands signals on weekly and monthly charts, confirming a healthy uptrend.

Derivatives Market Activity: Significant surges in open interest on 1 and 3 July (12.55% and 13.49% increases respectively) indicate fresh bullish positioning, despite a sharp drop in delivery volumes on the final day.

Conclusion

Apollo Hospitals Enterprise Ltd. demonstrated a resilient and well-supported uptrend during the week ending 3 July 2026. The stock’s multiple 52-week highs, strong financial results, and robust technical indicators combined with heightened derivatives market activity highlight a positive market consensus on its near-term prospects. While the midweek price dip and declining delivery volumes on the final day suggest some caution, the overall momentum remains firmly bullish. Investors and market participants should continue to monitor open interest trends and volume dynamics to gauge the sustainability of this rally within the hospital sector’s evolving landscape.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →